XML 70 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
Employee Benefit Plans
 12 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Employee Benefit Plans Employee Benefit Plans 
Stock Purchase Plan
During the three-year period ended December 31, 2024, our eligible employees could voluntarily participate in our employee stock purchase plan (“ESPP”) sponsored by us. Pursuant to the ESPP, employees may contribute an amount between 3% and 15% of their base salary and certain commissions. We contribute varying amounts as specified in the ESPP.
We contributed $34 million, $30 million and $36 million to the ESPP in the years ended December 31, 2024, 2023 and 2022, respectively, in accordance with our matching contribution.
FNF 401(k) Profit Sharing Plan
During the three-year period ended December 31, 2024, we have offered our employees the opportunity to participate in our 401(k) profit sharing plan (the “401(k) Plan”), a qualified voluntary contributory savings plan that is available to substantially all of our employees. Eligible employees may contribute up to 40% of their pre-tax annual compensation, up to the amount allowed pursuant to the Internal Revenue Code. During the year ended December 31, 2024, 2023 and 2022, we made an employer match on the 401(k) Plan of $0.50 on each $1.00 contributed up to the first 6% of eligible earnings contributed to the 401(k) Plan by employees. The employer match was $46 million, $45 million and $50 million for the years ended December 31, 2024, 2023 and 2022, respectively, and was credited based on the participant's individual investment elections in the FNF 401(k) Plan.
Omnibus Incentive Plan
In 2005, we established the FNT 2005 Omnibus Incentive Plan (as amended and restated, the “Omnibus Plan”) authorizing the issuance of up to 8 million shares of common stock, subject to the terms of the Omnibus Plan. On October 23, 2006; May 29, 2008; May 25, 2011; May 22, 2013; and June 15, 2016, the shareholders of FNF approved amendments to increase the number of shares for issuance under the Omnibus Plan by 16 million, 11 million, 6 million, 6 million and 10 million shares, respectively. The primary purpose of the increases were to assure that we had adequate means to provide equity incentive compensation to our employees on a going-forward basis. The Omnibus Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units and performance shares, performance units, other cash and stock-based awards and dividend equivalents. As of December 31, 2024, there were 2,357,220 shares of restricted stock and no stock options outstanding under the Omnibus Plan. Awards granted are approved by the Compensation Committee of the Board of Directors.
F&G Omnibus Incentive Plan
On June 1, 2020, in connection with the acquisition of F&G, we assumed the shares that remained available for future awards under the FGL Holdings 2017 Omnibus Incentive Plan, as amended and restated (the “F&G Omnibus Plan”) and converted such shares into 2,096,429 shares of FNF common stock that may be issued pursuant to future awards granted under the F&G Omnibus Plan and 2,411,585 shares of FNF common stock that may be issued pursuant to outstanding stock options under the F&G Omnibus Plan. Each unvested stock option assumed under the F&G Omnibus Plan was converted into an FNF stock option and vests solely on the passage of time without any ongoing performance-vesting conditions. The options vest over a 3 year period, based on the option's initial grant date, and have a contractual life of 7 years. As of December 31, 2024, there were no shares of restricted stock and 100,000 stock options outstanding under the F&G Omnibus Plan.
FNF stock option transactions under the Omnibus Plan for 2024, 2023, and 2022 are as follows:
 OptionsWeighted Average
Exercise Price		Exercisable
Balance, January 1, 2022996,113 $25.53 996,113 
Exercised(996,113)25.53  
Balance, December 31, 2022— $— — 

FNF stock option transactions under the F&G Omnibus Plan for 2024, 2023, and 2022 are as follows:
 OptionsWeighted Average
Exercise Price		Exercisable
Balance January 1, 20221,527,936 $35.97 1,072,584 
      Exercised (352,614)38.79 
      Canceled(2,715)28.00 
Balance, December 31, 20221,172,607 $35.15 1,172,607 
Exercised(502,414)30.31 
Canceled(26,570)38.07 
Balance, December 31, 2023643,623 $38.80 643,623 
Exercised(543,623)38.74  
Balance, December 31, 2024100,000 $39.10 100,000 
FNF restricted stock transactions under the Omnibus Plan in 2024, 2023 and 2022 are as follows:
 SharesWeighted Average Grant Date Fair Value
Balance, December 31, 20211,639,226 $41.97 
Granted994,548 40.83 
Vested(792,230)41.44 
Balance, December 31, 20221,841,544 $41.59 
Granted966,093 44.44 
Canceled(23,975)41.42 
Vested(908,267)40.26 
Balance, December 31, 20231,875,395 $43.69 
Granted1,604,119 60.23 
Canceled(16,603)45.92 
Vested(1,105,691)47.21 
Balance, December 31, 20242,357,220 $53.28 

FNF restricted stock transactions under the F&G Omnibus Plan in 2024, 2023 and 2022 are as follows:
 SharesWeighted Average Grant Date Fair Value
Balance, January 1, 2022718,641 $40.24 
      Granted — — 
      Canceled (78,551)37.79 
      Vested (138,542)34.11 
Balance, December 31, 2022501,548 $42.31 
Granted— — 
Canceled(15,965)45.63 
      Vested(304,104)42.87 
Balance, December 31, 2023181,479 $41.08 
Granted— — 
Canceled(13,082)48.28 
Vested(168,397)40.53 
Balance, December 31, 2024— $— 

The following table summarizes information related to stock options outstanding and exercisable as of December 31, 2024:
Options OutstandingOptions Exercisable
  Weighted   Weighted  
  AverageWeighted  AverageWeighted 
  RemainingAverage  RemainingAverage 
Range ofNumber ofContractualExerciseIntrinsicNumber ofContractualExerciseIntrinsic
Exercise PricesOptionsLifePriceValueOptionsLifePriceValue
  (In years) (In millions) (In years) (In millions)
$0.00 - $39.10
100,000 0.97$39.10 $2 100,000 0.97$39.10 $2 
 100,000 $2 100,000 $2 
We account for stock-based compensation plans in accordance with GAAP on share-based payments, which requires that compensation cost relating to share-based payments be recognized in the consolidated financial statements based on the fair value of each award. Using the fair value method of accounting, compensation cost is measured based on the fair value of the award at the grant date and recognized over the service period. Fair value of restricted stock awards and units is based on the
grant date value of the underlying stock derived from quoted market prices. In 2024, we issued a $50 million restricted stock grant to our chairman, of which one quarter of the grant vested immediately, with the remaining three quarters vesting in equal installments over a period of three years on each anniversary of the grant date. The total fair value of restricted stock awards granted in the years ended December 31, 2024, 2023 and 2022 was $97 million, $43 million and $41 million, respectively. The total fair value of restricted stock awards, which vested in the years ended December 31, 2024, 2023 and 2022 was $76 million, $51 million and $38 million, respectively. Option awards are measured at fair value on the grant date using the Black Scholes Option Pricing Model. The intrinsic value of options exercised in the years ended December 31, 2024, 2023 and 2022 was $9 million, $8 million and $16 million, respectively. Net earnings attributable to FNF Shareholders reflects stock-based compensation expense amounts of $82 million for the year ended December 31, 2024, $60 million for the year ended December 31, 2023 and $49 million for the year ended December 31, 2022, which are included in personnel costs in the reported financial results of each period.
At December 31, 2024, the total unrecognized compensation cost related to non-vested stock option grants and restricted stock grants is $98 million, which is expected to be recognized in pre-tax income over a weighted average period of 1.83 years.
Pension Plan
In 2000, FNF merged with Chicago Title Corporation ("CTC"). In connection with the merger, we assumed CTC’s noncontributory defined contribution plan and noncontributory defined benefit pension plan (the “Pension Plan”). The Pension Plan covers certain CTC employees. The benefits are based on years of service and the employee’s average monthly compensation in the highest 60 consecutive calendar months during the 120 months ending at retirement or termination. Effective December 31, 2000, the Pension Plan was frozen and there will be no future credit given for years of service or changes in salary. The accumulated benefit obligation is the same as the projected benefit obligation due to the pension plan being frozen as of December 31, 2000. Pursuant to GAAP on employers’ accounting for defined benefit pension and other post-retirement plans, the measurement date is December 31.
On May 1, 2023, we elected to terminate the Pension Plan, subject to approval by the Pension Benefit Guarantee Corporation and the receipt of a favorable determination letter from the IRS. Upon termination, the account balance of each participant in the Pension Plan shall become fully vested. Each remaining participant or beneficiary in the Pension Plan shall be given one of the following options with respect to termination of the Pension Plan: (i) a lump-sum distribution of the participant's account balance; or (ii) an annuity benefit equal to the participant’s account balance.
During the year ended December 31, 2024, we distributed substantially all of the Pension Plan assets to the participants or beneficiaries of the Pension Plan. As of December 31, 2024, the project benefit obligation and fair value of plan assets were immaterial. The discount rate used to determine the benefit obligation as of December 31, 2023 was 4.67%. As of December 31, 2023, the projected benefit obligation was $64 million and the fair value of plan assets was $54 million. The net pension liability and net periodic expense included in our financial position and results of operations relating to the Pension Plan is not considered material for any period presented.